Literature DB >> 11502070

TNF and TNFR biology in health and disease.

M F McDermott1.   

Abstract

Many insights have been gained into cytokine-regulated control of inflammatory processes and host defence in recent years. Evidence has also gradually accumulated that cytokine cascades play a central role in events regulating cell death and differentiation. Further developments include an understanding that the biological effects of the tumor necrosis factor-alpha (TNF-alpha or TNFSF) cytokine may be regulated by soluble TNF receptor binding and that modulation of receptor levels may permit physiological inhibition of TNF action. There has been a gradual realisation of the value of TNF/TNFR ratios as predictors of disease outcome, and the discovery of functional regulatory polymorphisms of the TNF gene and mutations of TNFRSF1A (TNFR1 receptor) have led to conceptual breakthroughs in our understanding of the genetic control of inflammation. However the exact mechanisms by which TNFRSF1A mutations give rise to disease susceptibility are not yet well understood. Over the past 10 years these concepts have been used as the basis for successful anti-TNF therapy of autoimmune diseases like rheumatoid arthritis (RA) and Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502070

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  44 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?

Authors:  Anna Cinkajzlová; Miloš Mráz; Martin Haluzík
Journal:  Protoplasma       Date:  2017-02-01       Impact factor: 3.356

3.  Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  T N C Magalhães; M Weiler; C V L Teixeira; T Hayata; A S Moraes; V O Boldrini; L M Dos Santos; B M de Campos; T J R de Rezende; H P G Joaquim; L L Talib; O V Forlenza; F Cendes; Marcio L F Balthazar
Journal:  Mol Neurobiol       Date:  2017-10-16       Impact factor: 5.590

4.  TNF-α/TNFR1 Signaling is Required for the Full Expression of Acute and Chronic Itch in Mice via Peripheral and Central Mechanisms.

Authors:  Xiuhua Miao; Ya Huang; Teng-Teng Liu; Ran Guo; Bing Wang; Xue-Long Wang; Li-Hua Chen; Yan Zhou; Ru-Rong Ji; Tong Liu
Journal:  Neurosci Bull       Date:  2017-04-01       Impact factor: 5.203

5.  ISSLS PRIZE IN CLINICAL SCIENCE 2018: longitudinal analysis of inflammatory, psychological, and sleep-related factors following an acute low back pain episode-the good, the bad, and the ugly.

Authors:  David M Klyne; Mary F Barbe; Wolbert van den Hoorn; Paul W Hodges
Journal:  Eur Spine J       Date:  2018-02-19       Impact factor: 3.134

6.  cDNA cloning and characterization of a new member of the tumor necrosis factor receptor family gene from scallop, Chlamys farreri.

Authors:  Jianguo Su; Limei Qiu; Ling Li; Lin Liu; Lingling Wang; Vinu S Siva; Dahui Yu; Linsheng Song
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

7.  Treatment of pediatric refractory Crohn's disease with thalidomide.

Authors:  Cui-Fang Zheng; Jia-Hua Xu; Ying Huang; Ying-Kit Leung
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

8.  T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection.

Authors:  B M Saunders; H Briscoe; W J Britton
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

9.  Infliximab as a therapy for non-Crohn's enterocutaneous fistulae.

Authors:  Ravindra S Date; Kanwar Jit Singh Panesar; Paul Neilly
Journal:  Int J Colorectal Dis       Date:  2004-06-03       Impact factor: 2.571

10.  TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection.

Authors:  Anna Zganiacz; Michael Santosuosso; Jun Wang; Tony Yang; Lihao Chen; Maria Anzulovic; Scott Alexander; Brigitte Gicquel; Yonghong Wan; Jonathan Bramson; Mark Inman; Zhou Xing
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.